NewBioRx produces BPC-157 using controlled solid-phase peptide synthesis (SPPS), followed by purification through high-performance liquid chromatography (HPLC) to remove truncated peptide fragments and synthesis byproducts
99% purity, HPLC tested, ideal for research reconstitution
GW: I think that, Eric, probably my favorite idea of the book was around the idea of at least we're starting to understand what are they markers of long-term decline
MAXILIV INJECTION is used to manage alcoholic fatty liver (disease that occurs due to heavy alcohol use), liver fibrosis/cirrhosis (scarring of liver due to excessive consumption of alcohol), and hepatitis (inflammation of liver) in affected individuals
Over 100 preclinical studies have been published on BPC-157, yet there are zero completed Phase III human clinical trials
Other compounds studied for related recovery mechanisms include BPC-157, TB-500, and the BPC-157/TB-500 blend